Drug Approval | June 12, 2025
FDA approves Merck’s enflonsia for prevention of RSV in infants
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
EBITDA before special items decreases to €4.08 billion (7.4%)
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Delivers robust earnings performance, successfully navigating a dynamic environment
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Overall investment in the US facility is estimated around US$50 million
Subscribe To Our Newsletter & Stay Updated
